共 50 条
- [4] Anti-CD19 CAR T cell therapy for lymphoma — off to the races! Nature Reviews Clinical Oncology, 2019, 16 : 279 - 280
- [5] Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy ONCOTARGETS AND THERAPY, 2021, 14 : 4023 - 4037
- [7] Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma FRONTIERS IN ONCOLOGY, 2024, 14
- [8] Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (08): : 783 - 784
- [9] Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma Nature Medicine, 2024, 30 : 507 - 518